<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on June 3, 2026 at 12:43 pm by All in One SEO Pro v4.9.7.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://infomeddnews.com/news-sitemap.xsl?news-sitemap=root"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
	<url>
		<loc><![CDATA[https://infomeddnews.com/ingenix-raises-e13m-from-sofinnova-partners-led-syndicate-to-scale-modality-fusion-a-novel-architecture-for-drug-development/]]></loc>
		<news:news>
			<news:publication>
				<news:name><![CDATA[Medical Device News Magazine]]></news:name>
				<news:language><![CDATA[en]]></news:language>
			</news:publication>
			<news:publication_date><![CDATA[2026-06-03T09:39:45+00:00]]></news:publication_date>
			<news:title><![CDATA[Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development]]></news:title>
		</news:news>
	</url>
	<url>
		<loc><![CDATA[https://infomeddnews.com/jjp-biologics-announces-positive-interim-phase-1b-data-for-nebaprubart-jjp-1212-an-anti-cd89-antagonist-in-linear-iga-disease-lad/]]></loc>
		<news:news>
			<news:publication>
				<news:name><![CDATA[Medical Device News Magazine]]></news:name>
				<news:language><![CDATA[en]]></news:language>
			</news:publication>
			<news:publication_date><![CDATA[2026-06-03T09:33:19+00:00]]></news:publication_date>
			<news:title><![CDATA[JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)]]></news:title>
		</news:news>
	</url>
	<url>
		<loc><![CDATA[https://infomeddnews.com/wegovy-pill-launches-in-the-uae-as-novo-nordisk-expands-global-access-to-obesity-care/]]></loc>
		<news:news>
			<news:publication>
				<news:name><![CDATA[Medical Device News Magazine]]></news:name>
				<news:language><![CDATA[en]]></news:language>
			</news:publication>
			<news:publication_date><![CDATA[2026-06-03T09:25:10+00:00]]></news:publication_date>
			<news:title><![CDATA[Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care]]></news:title>
		</news:news>
	</url>
	<url>
		<loc><![CDATA[https://infomeddnews.com/advanced-nanotherapies/]]></loc>
		<news:news>
			<news:publication>
				<news:name><![CDATA[Medical Device News Magazine]]></news:name>
				<news:language><![CDATA[en]]></news:language>
			</news:publication>
			<news:publication_date><![CDATA[2026-06-03T08:17:43+00:00]]></news:publication_date>
			<news:title><![CDATA[Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment]]></news:title>
		</news:news>
	</url>
	<url>
		<loc><![CDATA[https://infomeddnews.com/philips-receives-fda-510k-clearance-for-elevate-plus-for-epiq-elite-and-affiniti-delivering-ai-advancements-in-general-imaging-ultrasound/]]></loc>
		<news:news>
			<news:publication>
				<news:name><![CDATA[Medical Device News Magazine]]></news:name>
				<news:language><![CDATA[en]]></news:language>
			</news:publication>
			<news:publication_date><![CDATA[2026-06-02T20:51:49+00:00]]></news:publication_date>
			<news:title><![CDATA[Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound]]></news:title>
		</news:news>
	</url>
</urlset>